KDR and obesity due to melanocortin 4 receptor deficiency: Several reports have suggested that antivascular treatments could reduce body weight in mouse models of obesity [12], [13], [14], but whether antiangiogenic therapy by blockade of VEGFR1 or VEGFR2 can achieve this effect remains unknown.